CD44 and cancer: Based on bioinformatics analyses (Fig. 1B), CAR is significantly negatively correlated with the expression level of several key markers of cancer stem cells including CD24, CD44, CD133, and EpCAM. Thus, we verified the regulatory effect of CAR on stemness features.